Clinical Trial Update: Investigation of Drug-drug Interaction of Ritonavir and Itraconazole on the Pharmacokinetics of SHR-A1811 in Subjects With HER2-expressing Advanced Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the drug-drug interaction between ritonavir and itraconazole on the pharmacokinetics of SHR-A1811 in patients with HER2-expres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Itraconazole (Itraconazole)
• Ritonavir (Ritonavir)
• SHR-A1811

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Advanced Breast Cancer | Phase 1 | Status: RECRUITING